Business ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Manufacturing Product Development Research and Development Biosimilars Acquisitions Clinical Trials Oncology Radiopharmaceuticals Licensing Agreements

InnoCare and Eli Lilly Launch Collaboration to Co-Develop Oncology and Autoimmune Drugs

The pact pairs InnoCare’s discovery platform with Lilly’s development scale through conditional milestone payments and tiered royalties.

Alteogen Signs Option-and-License Deal With Novartis for ALT-B4 Worth Up to 4.4 Trillion Won

CSIR‑IICT Transfers IND‑Ready Plant Drug Candidate for Diabetic Foot Ulcers to Viridis Biopharma

Biocon Posts 53% Rise in Q1 Profit on Biopharma Recovery

FDA Approves Lytenava, First Ophthalmic Bevacizumab for Wet AMD

Johnson & Johnson Hits Record After Analyst Upgrade and Strong Drug Prescriptions

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

Pfizer Settles With Three Generics to Keep Vyndamax Exclusive Until 2031

Butantan Strikes Deal to Make CAR-T in Brazil as New Case Points to Wider Uses

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

AbbVie to Invest $380 Million in Two North Chicago API Plants

Dr Reddy’s Q3 Profit Drops 14% as North America Slows, India Surges and GLP‑1 Rollout Set

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

Okava Launches First GLP-1 Implant Trial for Overweight Cats

Telix Faces Securities Class Action Over Prostate Cancer Disclosures and Supply Chain Claims

Telix Hit With Securities Class Action Over Prostate-Drug Claims and Supply Chain Assurances